中恆集團(600252.SH)及子公司擬捐贈81.305萬元物資支持抗擊新冠肺炎疫情
格隆匯3月5日丨中恆集團(600252.SH)公佈,公司第九屆董事會第五次會議於2020年3月5日以通訊方式召開,會議審議通過《廣西梧州中恆集團股份有限公司關於定向捐贈約價值81.305萬元物資的議案》。
為支持抗擊新型冠狀病毒肺炎疫情,積極履行社會責任,同意公司及子公司向南寧市、梧州市捐贈81.305萬元人民幣物資,並授權公司經營管理層辦理具體捐贈事宜。加上此次捐贈,公司最近12個月累計對外捐贈1199.245萬元。
此次捐贈不會對公司生產經營產生重大影響,對公司當期及未來經營業績不構成重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.